Total Payments
$551.23
2024 Payments
$65.09
Companies
9
Transactions
37
Medicare Patients
343
Medicare Billing
$5,655
Payment Breakdown by Category
Food & Beverage$551.23 (100.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $551.23 | 37 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $361.79 | 26 | $0 (2024) |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $37.83 | 2 | $0 (2024) |
| Eisai Inc. | $37.00 | 2 | $0 (2021) |
| Phadia US Inc. | $34.42 | 2 | $0 (2023) |
| ITI, Inc. | $20.54 | 1 | $0 (2022) |
| AstraZeneca Pharmaceuticals LP | $16.95 | 1 | $0 (2021) |
| Lilly USA, LLC | $16.80 | 1 | $0 (2021) |
| GlaxoSmithKline, LLC. | $13.26 | 1 | $0 (2024) |
| Amgen Inc. | $12.64 | 1 | $0 (2022) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $65.09 | 4 | Salix Pharmaceuticals, a division of Bausch Health US, LLC ($37.83) |
| 2023 | $161.87 | 9 | ABBVIE INC. ($127.45) |
| 2022 | $221.02 | 18 | ABBVIE INC. ($187.84) |
| 2021 | $103.25 | 6 | Eisai Inc. ($37.00) |
All Payment Transactions
37 individual payment records from CMS Open Payments — Page 1 of 2
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 05/20/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $18.82 | General |
| Category: Gastroenterology | ||||||
| 04/24/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $19.01 | General |
| Category: Gastroenterology | ||||||
| 04/03/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $14.00 | General |
| Category: NEUROSCIENCE | ||||||
| 02/06/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug), AREXVY | Food and Beverage | In-kind items and services | $13.26 | General |
| Category: RESPIRATORY | ||||||
| 10/10/2023 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $26.85 | General |
| Category: NEUROSCIENCE | ||||||
| 09/14/2023 | Phadia US Inc. | ImmunoCAP (Device) | Food and Beverage | Cash or cash equivalent | $17.61 | General |
| Category: Allergy/Immunology | ||||||
| 08/17/2023 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $6.78 | General |
| Category: NEUROSCIENCE | ||||||
| 06/28/2023 | Phadia US Inc. | ImmunoCAP (Device) | Food and Beverage | Cash or cash equivalent | $16.81 | General |
| Category: Allergy/Immunology | ||||||
| 05/25/2023 | ABBVIE INC. | QULIPTA (Drug) | Food and Beverage | In-kind items and services | $27.09 | General |
| Category: NEUROSCIENCE | ||||||
| 04/28/2023 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $29.40 | General |
| Category: NEUROSCIENCE | ||||||
| 04/28/2023 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $4.40 | General |
| Category: NEUROSCIENCE | ||||||
| 03/16/2023 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $21.07 | General |
| Category: NEUROSCIENCE | ||||||
| 03/07/2023 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $11.86 | General |
| Category: NEUROSCIENCE | ||||||
| 10/28/2022 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $16.78 | General |
| Category: NEUROSCIENCE | ||||||
| 08/17/2022 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $12.58 | General |
| Category: NEUROSCIENCE | ||||||
| 08/02/2022 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $10.13 | General |
| Category: NEUROSCIENCE | ||||||
| 07/28/2022 | ITI, Inc. | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $20.54 | General |
| Category: PSYCHIATRY | ||||||
| 07/16/2022 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $7.82 | General |
| Category: NEUROSCIENCE | ||||||
| 07/08/2022 | ABBVIE INC. | QULIPTA (Drug) | Food and Beverage | In-kind items and services | $10.02 | General |
| Category: NEUROSCIENCE | ||||||
| 07/08/2022 | ABBVIE INC. | QULIPTA (Drug) | Food and Beverage | In-kind items and services | $2.55 | General |
| Category: NEUROSCIENCE | ||||||
| 07/07/2022 | ABBVIE INC. | QULIPTA (Drug) | Food and Beverage | In-kind items and services | $12.10 | General |
| Category: NEUROSCIENCE | ||||||
| 04/29/2022 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $4.38 | General |
| Category: NEUROSCIENCE | ||||||
| 04/27/2022 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $37.05 | General |
| Category: NEUROSCIENCE | ||||||
| 04/21/2022 | ABBVIE INC. | QULIPTA (Drug) | Food and Beverage | In-kind items and services | $12.42 | General |
| Category: NEUROSCIENCE | ||||||
| 04/19/2022 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $12.64 | General |
| Category: Inflammation | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 5 | 117 | 135 | $4,890 | $2,290 |
| 2022 | 5 | 145 | 185 | $6,280 | $3,004 |
| 2021 | 2 | 46 | 56 | $1,400 | $198.30 |
| 2020 | 1 | 35 | 47 | $1,175 | $162.65 |
Total Patients
343
Total Services
423
Medicare Billing
$5,655
Procedure Codes
13
All Medicare Procedures & Services
13 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 87426 | Detection test by immunoassay technique for severe acute respiratory syndrome coronavirus | Office | 2023 | 45 | 48 | $2,400 | $1,606 | 66.9% |
| 87804 | Detection test by immunoassay with direct visual observation for influenza virus | Office | 2023 | 18 | 21 | $840.00 | $327.97 | 39.0% |
| 87880 | Detection test by immunoassay with direct visual observation for streptococcus, group a (strep) | Office | 2023 | 11 | 11 | $275.00 | $154.70 | 56.3% |
| 81002 | Urinalysis, manual test | Office | 2023 | 29 | 38 | $950.00 | $129.58 | 13.6% |
| 93005 | Routine electrocardiogram (ecg) using at least 12 leads with tracing | Office | 2023 | 14 | 17 | $425.00 | $71.84 | 16.9% |
| 87426 | Detection test by immunoassay technique for severe acute respiratory syndrome coronavirus | Office | 2022 | 40 | 47 | $2,350 | $1,936 | 82.4% |
| 87804 | Detection test by immunoassay with direct visual observation for influenza virus | Office | 2022 | 31 | 32 | $1,280 | $496.06 | 38.8% |
| 87880 | Detection test by immunoassay with direct visual observation for streptococcus, group a (strep) | Office | 2022 | 16 | 17 | $425.00 | $260.01 | 61.2% |
| 81002 | Urinalysis, manual test | Office | 2022 | 45 | 74 | $1,850 | $254.23 | 13.7% |
| 93005 | Routine electrocardiogram (ecg) using at least 12 leads with tracing | Office | 2022 | 13 | 15 | $375.00 | $57.37 | 15.3% |
| 81002 | Urinalysis, manual test | Office | 2021 | 34 | 44 | $1,100 | $146.16 | 13.3% |
| 93005 | Routine electrocardiogram (ekg) with tracing using at least 12 leads | Office | 2021 | 12 | 12 | $300.00 | $52.14 | 17.4% |
| 81002 | Urinalysis, manual test | Office | 2020 | 35 | 47 | $1,175 | $162.65 | 13.8% |
About Benjamin Colvin, RN
Benjamin Colvin, RN is a Registered Nurse healthcare provider based in Montgomery, Louisiana. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 01/02/2013. The National Provider Identifier (NPI) number assigned to this provider is 1730425281.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Benjamin Colvin, RN has received a total of $551.23 in payments from pharmaceutical and medical device companies, with $65.09 received in 2024. These payments were reported across 37 transactions from 9 companies. The most common payment nature is "Food and Beverage" ($551.23).
As a Medicare-enrolled provider, Colvin has provided services to 343 Medicare beneficiaries, totaling 423 services with total Medicare billing of $5,655. Data is available for 4 years (2020–2023), covering 13 distinct procedure/service records.
Ad
Practice Information
- Specialty Registered Nurse
- Other Specialties Family
- Location Montgomery, LA
- Active Since 01/02/2013
- Last Updated 07/15/2013
- Taxonomy Code 163W00000X
- Entity Type Individual
- NPI Number 1730425281
Products in Payments
- VRAYLAR (Drug) $297.61
- QULIPTA (Drug) $64.18
- XIFAXAN (Drug) $37.83
- Dayvigo (Drug) $37.00
- ImmunoCAP (Device) $34.42
- CAPLYTA (Drug) $20.54
- FARXIGA (Drug) $16.95
- EMGALITY (Drug) $16.80
- TRELEGY ELLIPTA (Drug) $13.26
- Otezla (Drug) $12.64
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Registered Nurse Doctors in Montgomery
Mrs. Audrey Morgan, Np, NP
Registered Nurse — Payments: $18,317
Registered Nurse $18,317
Dr. Brandy Young, Dnp, Aprn, Fnp-C, DNP, APRN, FNP-C
Registered Nurse — Payments: $11,076
Registered Nurse $11,076
Josiah M Yance, Fnp-C, FNP-C
Registered Nurse — Payments: $9,058
Registered Nurse $9,058
Sari Capilouto, Crnp, CRNP
Registered Nurse — Payments: $8,590
Registered Nurse $8,590
Tara Felton, Np-C/Crnp, NP-C/CRNP
Registered Nurse — Payments: $6,470
Registered Nurse $6,470
Mrs. Jennifer Cox, Crnp, CRNP
Registered Nurse — Payments: $1,712
Registered Nurse $1,712